Mathew P Leese Selected Research

Breast Neoplasms (Breast Cancer)

9/2008	2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique.
3/2008	Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents.
3/2008	A new micronized formulation of 2-methoxyestradiol-bis-sulfamate (STX140) is therapeutically potent against breast cancer.
1/2008	STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells.
1/2006	The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells.
10/2005	Inhibition of MDA-MB-231 cell cycle progression and cell proliferation by C-2-substituted oestradiol mono- and bis-3-O-sulphamates.
8/2005	A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents.
4/2004	Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates.
2/2003	Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mathew P Leese Research Topics

Disease

14	Neoplasms (Cancer) 10/2015 - 02/2003
9	Breast Neoplasms (Breast Cancer) 09/2008 - 02/2003
3	Prostatic Neoplasms (Prostate Cancer) 02/2014 - 09/2007
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Endometriosis 01/2021
1	Neurofibrosarcoma (MPNST) 10/2015
1	Hypoxia (Hypoxemia) 10/2015
1	Multiple Myeloma 01/2014

Drug/Important Bio-Agent (IBA)

7	2- methoxyestradiol- 3,17- O,O- bis(sulfamate)IBA 10/2015 - 01/2006
6	2-MethoxyestradiolIBA 10/2015 - 02/2003
5	sulfamic acid (ammonium sulfamate)IBA 02/2014 - 02/2005
5	Steryl-Sulfatase (Steroid Sulfatase)IBA 04/2010 - 02/2003
4	Hormones (Hormone)IBA 10/2015 - 02/2005
2	Estrone FDA Link 01/2021 - 02/2005
2	Estrogens (Estrogen)FDA Link 01/2021 - 02/2005
2	2- methoxyestradiol- 3,17- bis- O,O- sulfamateIBA 09/2008 - 02/2003
1	EnzymesIBA 01/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2021
1	Progesterone FDA LinkGeneric 10/2015
1	2-ethyloestradiol-bis-sulfamateIBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	SteroidsIBA 04/2014
1	7- methoxy- 2- (3- methoxybenzyl)- 6- sulfamoyloxy- 1,2,3,4- tetrahydroisoquinolineIBA 02/2014
1	1,2,3,4-tetrahydroisoquinolineIBA 02/2014
1	EstersIBA 04/2010
1	Caspase 3 (Caspase-3)IBA 10/2009
1	SurvivinIBA 10/2009
1	2- methoxy- 3- O- sulfamoyl- 17- cyanomethylestra- 1,3,5(10)- trieneIBA 10/2009
1	2-ethylestradiol sulfamateIBA 09/2008
1	Angiogenesis InhibitorsIBA 09/2008
1	2- methoxyoestra- 1,3,5(10),16- tetraene- 3- carboxamideIBA 05/2008
1	Antineoplastic Agents (Antineoplastics)IBA 03/2008
1	Docetaxel (Taxotere)FDA Link 01/2008
1	taxaneIBA 01/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2008
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 09/2007
1	Oxidoreductases (Dehydrogenase)IBA 01/2006
1	Estrogen Receptor alphaIBA 10/2005
1	2-methoxyestroneIBA 04/2004
1	2-methoxyestriolIBA 02/2003

Therapy/Procedure

2	Therapeutics 10/2015 - 02/2005
1	Withholding Treatment 09/2007